Source: PRLog

Press Release: Bioo Scientific : Bioo Scientific Launches BRCA1/2 Amplicon Panel for Detection of Somatic Mutations in FFPE Samples

Bioo Scientific recently launched the NEXTflex BRCA1 and BRCA2 Amplicon Panel for FFPE Illumina-Compatible Sequencing, for the detection of clinically relevant somatic mutations in the BRCA1/2 genes from DNA isolated from FFPE samples.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

President & CEO

Joseph W.

CEO Approval Rating

68/100

Read more